Daily Star on MSN
Drug-resistant 'super fungus' that attacks groin and bum spreads through UK and can be transmitted by sex
Cases of trichophyton indotineae - a drug-resistant fungal infection that causes unsightly skin lesions all over the body - ...
To tackle this growing issue, THINK! are launching an impactful new campaign – ‘Don’t Put Drugs in the Driving Seat’ . The ...
The UK drug development process is evolving. Find out how government efforts are reducing clinical trial timelines for new ...
An international team involving the Institute of Chemical Research, a joint centre of the University of Seville and the ...
Sept 29 (Reuters) - AbbVie (ABBV.N), opens new tab said on Monday it would launch its ovarian cancer drug Elahere in the UK at a list price matching that in the U.S. President Donald Trump has been ...
The price the NHS pays for medicines will need to rise to stop a wave of pharmaceutical investment leaving the UK, science minister Patrick Vallance has said. His comments follow several recent ...
Journavx has possible interactions with some other drugs, certain foods, and certain supplements. Examples include grapefruit and certain hormonal contraceptives. Talk with your doctor to avoid ...
Background: Failure to detect significant drug interactions may result in adverse outcomes. While proper screening and management of drug interactions can prevent the majority of adverse events, ...
The UK Government is pushing itself to become a world leader in AI-powered drug discovery with new investments and global partnerships announced during London’s Tech Week OpenBind is the research ...
DEAR DR. ROACH: I am an 84-year-old male in fairly good health for my age. I take 8-10 pills a day, including two over-the-counter medications. I take four or five in the morning and four or five in ...
Harry Sumnall receives funding from public grant awarding bodies for alcohol and other drugs research, and fees from (international) not-for-profit organisations and government departments for ...
Clinical Outcomes and Efficacy of Human Epidermal Growth Factor Receptor 2–Targeted Therapy in Breast Cancer With Uncommon In Situ Hybridization Patterns or Discordant Immunohistochemistry The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results